Skip to main content
See every side of every news story
Get Started
SubscribeLogin
Published • loading... • Updated

Endpoints 11: ByteDance makes more than TikToks, with biotech spinout Anew Labs turning into a formidable China rival in AI bio

Summary by endpoints.news
Endpoints 11 2026 winner Anew Labs is ByteDance's AI drug startup and has raised $290M at a $1.5B valuation
DisclaimerThis story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.

1 Articles

endpoints.newsendpoints.news

Endpoints 11: ByteDance makes more than TikToks, with biotech spinout Anew Labs turning into a formidable China rival in AI bio

Endpoints 11 2026 winner Anew Labs is ByteDance's AI drug startup and has raised $290M at a $1.5B valuation

Read Full Article
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • There is no tracked Bias information for the sources covering this story.

Factuality Info Icon

To view factuality data please Upgrade to Premium

Ownership

Info Icon

To view ownership data please Upgrade to Vantage

endpoints.news broke the news on Friday, September 25, 2026.
Too Big Arrow Icon
Sources are mostly out of (0)
Blindspot Title And Logo
Stories disproportionately reported by the Left or the Right

Similar News Topics

ByteDance icon

ByteDance

China icon

China

News
Feed Dots Icon
For You
Search Icon
SearchBlindspot LogoBlindspotLocal